TOKIWA-Bio is a venture company that develops Stealth RNA Vectors (SRV), which is an innovative
technology for gene expression systems, and is aims to realize gene cell therapy and regenerative medicine. SRV is the world’s first RNA vector that realizes long-term stable gene expression in the cytoplasm, and it is practical to simultaneously load more than 10 genes in a single RNA vector. TOKIWA-Bio persist in developing highly safe vector for gene therapy and contribute to people suffering from genetic diseases around the world.
選單